Dyadic International (DYAI) EPS (Diluted) Growth (1y) (2025 - 2026)
Powered by 
Analysis
Dyadic International (DYAI) EPS (Diluted) Growth (1y) (2025 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.78 Bn | 192.79 Bn | 7.24 Bn | 64.94% |
| 2 | Gilead Sciences | 179.92 Bn | 176.74 Bn | 6.22 Bn | -640.40% |
| 3 | Vertex Pharmaceuticals | 131.39 Bn | 123.54 Bn | 2.84 Bn | 8.02% |
| 4 | Regeneron Pharmaceuticals | 81.91 Bn | 73.91 Bn | 3.93 Bn | -4.52% |
| 5 | Argenx Se | 60.35 Bn | 55.17 Bn | 1.37 Bn | 89.89% |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn | 7.59% |
| 7 | Alnylam Pharmaceuticals | 33.12 Bn | 29.81 Bn | 992.69 Mn | 315.14% |
| 8 | Biogen | 31.92 Bn | 30.63 Bn | 1.96 Bn | -84.85% |
| 9 | Roivant Sciences | 29.23 Bn | 29.23 Bn | 1.16 Mn | - |
| 10 | Dyadic International | 17.65 Mn | 9.69 Mn | - | 21.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 21.72% |
| Dec 31, 2025 | 9.84% |
| Sep 30, 2025 | -914.74% |
| Jun 30, 2025 | 13.60% |